Natriuretic peptide hormone measurement in acute coronary syndromes
- PMID: 14574059
- DOI: 10.1023/a:1026103601075
Natriuretic peptide hormone measurement in acute coronary syndromes
Abstract
Cardiac Ischemia is an important trigger for the release of B-type natriuretic peptide (BNP). BNP and N-terminal pro-BNP (N-proBNP) are emerging as important biomarkers for risk stratification in patients with acute coronary syndromes. Higher levels of BNP and pro-BNP are associated with a greater risk for death and heart failure, independent of traditional clinical variables and levels of other biomarkers such as troponins and C-reactive protein. The therapeutic implications of these findings are not yet known.
Similar articles
-
[Natriuretic peptides and multimarker approach to risk stratification of patients with acute coronary syndromes].Med Pregl. 2006 May-Jun;59(5-6):248-52. doi: 10.2298/mpns0606248m. Med Pregl. 2006. PMID: 17039908 Review. Serbian.
-
Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes.Clin Chim Acta. 2004 Aug 16;346(2):119-28. doi: 10.1016/j.cccn.2004.04.004. Clin Chim Acta. 2004. PMID: 15256312 Review.
-
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.Circulation. 2002 Apr 16;105(15):1760-3. doi: 10.1161/01.cir.0000015464.18023.0a. Circulation. 2002. PMID: 11956114
-
Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.J Am Heart Assoc. 2017 May 29;6(6):e004743. doi: 10.1161/JAHA.116.004743. J Am Heart Assoc. 2017. PMID: 28554908 Free PMC article. Clinical Trial.
-
B-type natriuretic peptide molecular forms for risk stratification and prediction of outcome after acute myocardial infarction.Am Heart J. 2018 Jun;200:37-43. doi: 10.1016/j.ahj.2018.02.016. Epub 2018 Mar 3. Am Heart J. 2018. PMID: 29898847
Cited by
-
Cardioprotective actions of peptide hormones in myocardial ischemia.Heart Fail Rev. 2007 Dec;12(3-4):279-91. doi: 10.1007/s10741-007-9029-y. Heart Fail Rev. 2007. PMID: 17516166 Review.
-
What Is High Enough? Elevated NT-pro-BNP in Decompensated Paroxysmal Supraventricular Tachycardia.J Pediatr Intensive Care. 2018 Mar;7(1):49-53. doi: 10.1055/s-0037-1603760. Epub 2017 Jun 12. J Pediatr Intensive Care. 2018. PMID: 31073468 Free PMC article.
-
Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases.Heart Fail Rev. 2010 Jul;15(4):293-304. doi: 10.1007/s10741-009-9142-1. Heart Fail Rev. 2010. PMID: 19360468 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials